A sudden increase in demand has been observed in some states for Amphotericin B which is being actively prescribed by the physicians to patients suffering from Mucormycosis, a post COVID complication. The Government of India is therefore engaging with the manufacturers to ramp up production of the drug. The supply position is expected to improve with extra imports of this drug and increase in its production domestically.
- Read more about Government take steps to ramp up availability of Amphotericin B - to fight Mucormycosis
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2021/government-take-steps-to-ramp-up-availability-of-amphotericin-b-to-fight-mucormycosis
No comments:
Post a Comment